ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Japan-Update

Japanese bioventures receiving healthy dose of investor funds

Top-tier bio startups rack up record market capitalization

TOKYO -- Japanese deregulation and partnerships with established drugmakers have led to a renaissance among domestic bioventures as investors shower funds in anticipation of the next big patent.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more